RecruitingNot ApplicableNCT05873608

Communication Issues in Patient and Provider Discussions of Immunotherapy

Communication Issues in Patient/Provider Discussions of Immunotherapy

Sponsor

Emory University

Enrollment

125 participants

Start Date

Oct 6, 2016

Study Type

INTERVENTIONAL

Conditions

Malignant Solid Neoplasm Hematopoietic and Lymphoid System Neoplasm

Summary

This trials studies communication issues in patient and provider discussions about immunotherapy. The goal of this study is to describe where patients have heard about immunotherapy, what the participants understand about it, how physicians and other healthcare workers describe immunotherapy, and how educational videos may support patient knowledge about immunotherapy.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Educational video, Interview, and others for people with hematopoietic and lymphoid system neoplasm and malignant solid neoplasm. The study is currently recruiting participants at 2 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEREducational video

Testing an educational video

OTHERInterview

Participate in interview

OTHERObservation

Undergo observation

Locations(2)

Emory University Hospital/Winship Cancer Institute

Atlanta, Georgia, United States

Atlanta VA Medical Center

Decatur, Georgia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05873608

Related Trials

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

NCT06126276188 locations

Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation

NCT072355011 location

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

NCT06513962205 locations

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

NCT050923731 location

Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Survivors

NCT069413241 location